Amrutanjan Health Care Limited - Asset Resilience Ratio

Latest as of September 2025: 61.39%

Amrutanjan Health Care Limited (AMRUTANJAN) has an Asset Resilience Ratio of 61.39% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Amrutanjan Health Care Limited (AMRUTANJAN) working capital ratio to evaluate short-term liquidity relative to the company's equity base.

Liquid Assets

Rs2.65 Billion

≈ $28.70 Million USD Cash + Short-term Investments

Total Assets

Rs4.32 Billion

≈ $46.76 Million USD All company assets

Resilience Assessment

Very High

Financial Resilience Level

Asset Resilience Ratio Trend (2006–2025)

This chart shows how Amrutanjan Health Care Limited's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see balance sheet size of Amrutanjan Health Care Limited.

Liquid Assets Composition Over Time

This chart breaks down Amrutanjan Health Care Limited's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Explore long-term investment intensity of Amrutanjan Health Care Limited to see how much of total assets are deployed in long-term investments.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	Rs631.16 Million	14.6%
Short-term Investments	Rs2.02 Billion	46.79%
Total Liquid Assets	Rs2.65 Billion	61.39%

Asset Resilience Insights

Very High Liquidity: Amrutanjan Health Care Limited maintains exceptional liquid asset reserves at 61.39% of total assets.
This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
The company has significant short-term investments, indicating active treasury management.

Amrutanjan Health Care Limited Industry Peers by Asset Resilience Ratio

Compare Amrutanjan Health Care Limited's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Swedish Orphan Biovitrum AB (publ) ST:SOBI	Drug Manufacturers - Specialty & Generic	1.54%
Yunnan Baiyao Group Co Ltd SHE:000538	Drug Manufacturers - Specialty & Generic	8.38%
Guangdong Zhongsheng Pharmaceutical Co Ltd SHE:002317	Drug Manufacturers - Specialty & Generic	6.62%
Takeda Pharmaceutical Co Ltd ADR NYSE:TAK	Drug Manufacturers - Specialty & Generic	4.94%
Harbin Gloria Pharmaceuticals SHE:002437	Drug Manufacturers - Specialty & Generic	9.04%
Jiuzhitang Co Ltd SHE:000989	Drug Manufacturers - Specialty & Generic	7.86%
Renhe Pharmacy Co Ltd SHE:000650	Drug Manufacturers - Specialty & Generic	37.54%
Jiangsu Kanion Pharmaceutical Co Ltd SHG:600557	Drug Manufacturers - Specialty & Generic	0.29%

Annual Asset Resilience Ratio for Amrutanjan Health Care Limited (2006–2025)

The table below shows the annual Asset Resilience Ratio data for Amrutanjan Health Care Limited.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-03-31	43.93%	Rs1.85 Billion ≈ $20.02 Million	Rs4.21 Billion ≈ $45.57 Million	-11.53pp
2024-03-31	55.46%	Rs2.03 Billion ≈ $22.00 Million	Rs3.67 Billion ≈ $39.68 Million	+18.67pp
2023-03-31	36.79%	Rs1.33 Billion ≈ $14.41 Million	Rs3.62 Billion ≈ $39.16 Million	+3.18pp
2022-03-31	33.61%	Rs1.18 Billion ≈ $12.72 Million	Rs3.50 Billion ≈ $37.84 Million	+17.34pp
2021-03-31	16.28%	Rs446.38 Million ≈ $4.83 Million	Rs2.74 Billion ≈ $29.66 Million	-2.72pp
2020-03-31	19.00%	Rs390.11 Million ≈ $4.22 Million	Rs2.05 Billion ≈ $22.21 Million	-14.96pp
2019-03-31	33.95%	Rs637.04 Million ≈ $6.89 Million	Rs1.88 Billion ≈ $20.29 Million	-26.18pp
2018-03-31	60.14%	Rs998.17 Million ≈ $10.79 Million	Rs1.66 Billion ≈ $17.95 Million	+55.48pp
2017-03-31	4.66%	Rs75.82 Million ≈ $819.93K	Rs1.63 Billion ≈ $17.60 Million	+4.58pp
2015-03-31	0.08%	Rs1.02 Million ≈ $10.98K	Rs1.24 Billion ≈ $13.40 Million	-0.01pp
2014-03-31	0.09%	Rs1.06 Million ≈ $11.42K	Rs1.20 Billion ≈ $13.01 Million	+0.03pp
2013-03-31	0.06%	Rs766.55K ≈ $8.29K	Rs1.24 Billion ≈ $13.43 Million	-2.44pp
2012-03-31	2.50%	Rs35.93 Million ≈ $388.57K	Rs1.43 Billion ≈ $15.52 Million	+1.82pp
2006-03-31	0.68%	Rs2.52 Million ≈ $27.27K	Rs370.01 Million ≈ $4.00 Million	--

pp = percentage points

About Amrutanjan Health Care Limited

NSE:AMRUTANJAN India Drug Manufacturers - Specialty & Generic

Market Cap

$154.33 Million

Rs14.27 Billion INR

Market Cap Rank

#17644 Global

#941 in India

Share Price

Rs493.80

Change (1 day)

+0.57%

52-Week Range

Rs488.25 - Rs759.40

All Time High

Rs971.56